chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; Information has been received regarding a case in litigation from a lawyer and the patient (pt) on 24-SEP-2020, referring to a pt of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2013, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for the long-term prevention of shingles and zoster related conditions by a health care provider (HCP). On an unspecified date, the pt suffered and subsequently treated by a nurse practitioner for the following injuries as a result of the zoster vaccine live (ZOSTAVAX) vaccine: shingles. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
red mark at the outside side of the thumb base; had shingles on her left thumb and hand; 8-10 blisters /  3 blisters in the palm side of the thumb base; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st May 2020, the patient received the 1st dose of Shingrix. On 5th July 2020, 45 days after receiving Shingrix, the patient experienced shingles and blister. On an unknown date, the patient experienced erythema. On an unknown date, the outcome of the shingles and erythema were unknown and the outcome of the blister was recovered/resolved.   It was unknown if the reporter considered the shingles, blister and erythema to be related to Shingrix.  Additional details were reported as follows: The patient received 1st dose of shingrix in left arm and experienced shingles on left thumb and hand with around 8-10 blisters on the outer part of the thumb base and around 3 blisters in the palm side of the thumb base. The reporter mentioned that blisters were resolved but had a red mark at the outside of the thumb base of the left hand. The reporter consented to follow up.
Pt received second dose of fluarix vaccine on 3/28/23 in error. Pt had previously received fluarix dose on 10/13/22.
First dose caused no noticeable symptoms. Second dose caused fatigue and intense brain fog. I (patient) expected symptoms to subside, but they did not. Now over a month later (May 27, 2021), still experiencing brain fog symptoms as follow: cognitive impairment, short and long term memory loss, difficulty finding/saying certain words. Symptoms are akin to a geriatric dementia patient, but in an otherwise healthy 33 y/o male with no underlying conditions. Onset of symptoms was acute following vaccination.
Pt initially reported her allergies when questioned and that she has difficulty breathing and vaccinator advised her not to take the vaccine. She requested to speak to supervisor. Clinic manager came to speak to Pt and when asked to confirm that she has difficulty breathing w/ allergies, she denied it. Clinic manager spoke to medical advisor was told that since she answered yes to question 2, she could receive vaccination but would need to be monitored for 30 minutes. Clinic manager explained this to Pt. and also informed her that if she had any s/s of anaphylaxis, an epipen would be administered and 911 would be called; Pt. agreed. At 11:40 Pt complained of feeling dizzy, unsteady gait. PHN had her lie down at 1140am and offered water. She also reported a headache and feeling cold. Pt was conscious, but appeared weak. 1210pm, pt still c/o dizziness. At 12:45pm c/o nausea, no vomiting. AT 12:46pm she appeared to faint, 911 called. Handed off patient to paramedics at 1:05pm. Transported to local hospital 13:10.
lt arm bruising 1 1/2 diameter, swelling & hardness, hot to touch, used ice off & on to area;tender to touch;noticeable petchiae in center of bruising;rxn @ inj site;
This spontaneous report was received from a 63 year old male patient referring on himself. The patient reported that he had nasal surgery for his sinus and Lasik eye surgery on both of his eyes, on approximately 2003 (reported as "about 15 years ago"). The patient's concurrent conditions were not provided. The patient's concomitant medications included vitamin D, mineral over the counter Aspirin and pregabalin (LYRICA). On approximately 2013 (reported as "about 5 years ago") the patient was vaccinated with (ZOSTAVAX for prevention of shingles (strength, lot # and expiration date were not provided). Three weeks after he received the vaccination he broke out in a rash all over his body, he said it was like shingles, but it was not shingles, it was everywhere.. The physician at that time sent the patient to an Allergist and a Dermatologist, but there was no resolution to the cause of the rash; therefore the patient was placed on a regimen of steroids (unspecified names and dosages) and then on a regimen on antihistamines (unspecified names and dosages) multiple times. Each time toward the end of the treatment the rash would come back. Also on approximately January 2017 (reported as " for the past 4 months"), the patient had floaters in his vision and flashes of light that are to the right side of his vision area. It was like he had a retinal detachment or acute necrotizing retinitis. The patient also stated that he had not seen any eye doctor about this yet, but would be scheduling an appointment soon. At the time of the report, the patient had not recovered from the events.  The causal assessment between the events and ZOSTAVAX was not reported. Upon internal review the acute necrotiziting retinitis and retinal detachment were considered medically significant.
VAERS REPORT WRITE-UP FOR MY MOTHER, KILLED BY MODERNA ON 08/15/22   On August 15, 2022, my Mother died from a sudden cardiac event while vacationing.  She visits every August for 2-3 weeks.  SHE HAD NO HEART ISSUES.  NO UNDERLYING BLOOD PRESSURE OR CARDIAC EVENTS IN HER ENTIRE LIFE.  She did not have one single underlying major medical condition.  No cancer, no autoimmune issues, no asthma, no lung problems. Perfect weight.  Active until the day she died both physically and mentally. Walked up to 3 miles a day, read every night before she went to sleep and played bridge weekly her entire adult life.     Her mind was sharp as a tack, and she never even had a bout with depression.  She lived a stress-free life by enjoying sports, her friends, volunteering at the local community center and participating in her grandchildren?s lives.  She was not taking any prescription medications.  She traveled often.  She had NO PROBLEMS while on vacation. She was active every single day.  On Monday, August 15th her sister heard her wake up at 6 am to use the bathroom, and when she went to tell her coffee was ready at 8 am she had passed.  In under two hours.  For no reason. LIKE SOMEONE TURNED OFF THE LIGHTSWITCH TO HER HEART.   The ONE PROBLEM SHE DID HAVE was FOUR SHOTS OF MODERNA MRNA COVID-19 VACCINE.  THE ONLY COMMON DENOMINATOR. THE LAST BOOSTER WAS 4/26/21.  FOUR SHOTS WITHIN FIFTEEN MONTHS of a toxic pharmaceutical put in a 125 lb. body killed her.  Moderna has THREE TIMES the amount of lipid nanoparticles than the other bioweapon Pfizer.  She was told to take those shots by her government up and down the line.  Using all sorts of scare tactics.  From the County Public Health Director to Health and Human Services Secretary.  MY MOM DID NOT LIVE IN FEAR.  BUT SHE BELIEVED IN FOLLOWING THE RULES.  DO AS YOU ARE TOLD BY THE POWERS THAT BE.  THAT IS THE WAY SHE WAS RAISED AND NOW THE WAY SHE DIED TOO.   HER SHOT HISTORY:   01/27/21:  #-029L20A   02/24/21: #011A21A   11/12/21: #032F21A   04/26/22: #056A22A   HERE ARE THE LINKS TO THE CORRESPONDING DEATH REPORTS IN VAERS FOR THESE EXACT TOXIC BATCH #?S.  YOU NEED TO RECALL THESE TOXIC BATCHES AND NOTIFY THE PUBLIC ACCORDINGLY.   #029L20A:     #011A21A     #032F21A     #056A22A    MY MOTHER DIED ON 8/15/22. MEDICAL MURDER. CLEAR AS DAY.       ?THERE WILL BE JUSTICE. PRESERVE YOUR DOCUMENTS.?
I have been taking tamoxifen since September 2020 and have not had a menstrual period since then.  Prior to that time, I would menstruate regularly, with a very light cycle.    Approximately 17 hours after my first Covid 19 vaccination, I started menstruating very heavy with large clots for 3 days. Approximately 60 hours after my second Covid 19 vaccination, I started menstruating very heavy with large clots for 3 days.
The day after the vaccine I had chills and body aches and then a day or two following that I started having daily hot flashes and night sweats.  The hot flashes and night sweats that have continued since.  I had a hysterectomy 2 years ago with one ovary remaining.  The last we checked I still had estrogen producing hormones and wasn't in perimenopause or menopause yet.
Drug ineffective; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Nov2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 57 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Gabapentin, reaction(s): "Drug allergy"; Morphine, reaction(s): "Drug allergy". The following information was reported: COVID-19 (medically significant) with onset 28Mar2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 28Mar2023, outcome "unknown", described as "Drug ineffective ". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Mar2023) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received no other medication in 2 weeks at the time of reporting. The patient was treated with Paxlovid (Batch/Lot number: GF7861) from 31Mar2023 to Apr2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300143213 Same patient, different product, different event;
77 patients received Moderna bivalent booster doses that had undergone a temperature excursion; 77 patients received Moderna bivalent booster doses that had undergone a temperature excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion).    Concomitant product use was not provided by the reporter.  On an unknown date, the patient received Moderna bivalent booster dose that had undergone a temperature excursion. The dose was administered before it was known if the vaccine was ok.  Treatment information was not provided.  This case contains information for 74th of 77 adult patients described by the reporter.   This case was linked to MODERNATX, INC.-MOD-2023-696122 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-696122: Master case
About 15 mins after Echo Tech at the hospital, working when received the vaccine received her vaccine she returned and said the sight was itching, I assessed the sight and it was red, raised, swollen, and irritated looking. I removed the band aid and cleaned the sight with alcohol. She said she wasn't having any respiratory or cardiac symptoms. Her vital signs were stable. I told her I thought it might be the band aid and to let it air out and I would check on her in 30 mins, I informed her she could be seen at the clinic or if she experienced any shortness of breath or cardiac symptoms to go to the ER.  When I went to check on her 30 mins later, the sight was no longer red, but was edematous and hot. She said she had a few cardiac palpitations. I asked if she want to go to the ER, she said no. I told her to take Motrin now and Benadryl when she got home. Also she could put a cold pack on if it became too uncomfortable.
Subsequent to receiving  one dose of varicella virus vaccine live the pt experienced 10-12 3mm erythematous papules on the trunk. The was no fever or constitutional signs.
Facial rash within 5 minutes of vaccine , macular rash and treated with benadryl resolved in 30 minutes
Got 2nd Moderna shot. 8 days later got extremely dizzy, felt pain all over body, threw up. Taken to hospital . Given blood transfusion that worked. Spent  5 days in ICU; 2 days in regular hospital room. NOT ENTIRELY SURE THAT VACCINE CAUSED IT. Doctors say unlikely but possible so I felt I should report it since it was so close in time to getting vaccine and I never had those problems before. Blood pressure got so low that doctors say I would have died without the transfusion.      After 1st Moderna shot (Jan. 15,2021) had only slightly dizzy, heart rate increased significantly and blood pressure went very high. All of those 1st shot issues went away in about half an hour. Serious problems only occurred after 2nd shot. Scarred to get booster next year unless doctors find that vaccine was not the cause of problem.
Initial case received from a consumer on 11 October 2012. An unidentified patient, sex, age not provided, received a tetanus vaccine, manufacturer unknown, on an unspecified date. The patient experienced Bells Palsy after the vaccination on an unspecified date. Patient medical history, relevant history, relevant lab tests and concomitant medications were not reported. The reporter declined to provide patient details or contact information or reporter contact information. This case is invalid due to patient information details and reporter contact information was not reported. No further details available at the time of this report. Patient outcome is unknown. Documents held by sender: None.
The patient complained of some shortness of breath and dizziness beginning approximately 2 weeks after receiving the second Moderna Covid vaccine (first dose April 2, 2021, second dose May 5, 2021)
Presented for induction of labor and underwent uncomplicated SVD; incidental finding of COVID+, asymptomatic
A headache began at 2:00 am. the next day. The headache lasted all day. By 3:30 pm (the next day) I had body aches that got progressively worse all day and I was extremely tired. By 6:00 pm I also had chills and I felt cold. This lasted all night. In the morning I felt  tired, but the body aches, chills and headache were gone.
Felt dizzy, blurry vision which turned to foggy vision. BP 100/60 pulse 80 R 24. Mother took student home to rest. Mother will call primary doctor if symptoms persists or worsen. 3pm telephone call with mother pt recovered.
Got covid after receiving the first vaccine; Got covid after receiving the first vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Got covid after receiving the first vaccine". Clinical course: The patient asked what was the longest time frame one can go when got first Pfizer shot and before the second shot. She asked if it was recommended 21 days apart. She stated that she had an emergency come up that past Friday, which was the day she was supposed to get her second Pfizer Covid-19 vaccine. She wondered if she can get her vaccine that day. She was not sure if she needed to wait 30 days. Caller also provided that she got covid after receiving the first vaccine. She asked how long she needed to wait to receive the second dose after having covid and In how many months was the vaccine no longer effective. She stated that given that the CDC recommends waiting 3 months to receive the second dose after covid, she asked would they give it to her then, she also asked the CDC number.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Client vaccinated at approximately 3 pm-went by car with mom. Arrived at mom's work-vomited once. Given sip of water and taken back to Health Center-presented unresponsive, right lateral deviation of both eyes (approx. 1 hour after vaccines). Foaming at mouth. Mild hypoxia - resolved by O2 by nasal cannula. EMS took to ER. No history of trauma or fall.
by 7:30 pm on the day of the vaccine, I noticed all my joints where achy.  I went to bed approximately 10 pm  and during the night I had fever, chills, increasing joint pain and swelling, headache, extreme fatigue and malaise.  I continue to have joint pain and swelling, parathesia, headache and fatigue as of today although it is not as bad as the first day.
vaccination site pain; Sinus infection; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) and SINUSITIS (Sinus infection) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    Concomitant products included METHOTREXATE for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and SINUSITIS (Sinus infection). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and SINUSITIS (Sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was unknown.
vasovagal syncope or seizure? After receiving the drive-through vaccine, we drove into a parking space to sit and make sure I was ok. Within 5-10 minutes, I was sitting in the car and sending a text and with no warning whatsoever mid-text lost consciousness, profuse sweating, wheezing, lost color in my skin, was making unintelligible noises, and eventually woke up about a minute later but couldn't speak or comprehend those speaking to me (according to my wife who was terrified).  I was not nervous, stressed, or scared of receiving a vaccine. I regained the ability to speak about a minute later and my wife had summoned the staff on the scene who instructed me to lie back and breathe without a mask. I drank some liquids. A nurse was called over and offered to take my vital signs but I decided I felt ok enough not to. Eventually my normal skin color and came back and sweating stopped after about 5 minutes. We sat for a few extra minutes and once I felt it was past me,  my wife drove us home.